Trump administration will fund new research on controversial psychedelic drug ibogaine

WASHINGTON — Federal officials on Thursday announced new funding to explore the medical potential of ibogaine, a controversial psychedelic drug championed by veterans, conservative lawmakers and podcasters aligned with President Donald Trump.Health Secretary Robert F. Kennedy Jr. said his department is awarding up to $4.9 million to prepare for the first U.S. studies of ibogaine…

We have curated content aggregated from various sources. We also have curated books, reports and contributor articles. Be an agrifrica subscriber and be informed about the importance of the Business of Farming, Green and Blue Economies and Climate Change. This content is for AGRIFRICA SUBSCRIPTION members only.
Register
Already a member? Log in here